Yep agree Dilson. IAM would be very close to revenue neutral with the 15 Sentry branches...... depending on their sizes they could be well in front even on current quarterly spend. I largely think the announcement tomorrow will put a nail in that particular coffin for good IMO. DB
- Forums
- ASX - By Stock
- CF1
- Ann: Appendix 4D and Half-Year Report and Accounts
Ann: Appendix 4D and Half-Year Report and Accounts, page-26
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CF1 (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $15.33M |
Open | High | Low | Value | Volume |
2.5¢ | 2.7¢ | 2.5¢ | $1.656K | 63.15K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 335344 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 280000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 335344 | 0.025 |
2 | 543750 | 0.024 |
1 | 75000 | 0.023 |
1 | 250000 | 0.021 |
1 | 103307 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 280000 | 1 |
0.030 | 500000 | 1 |
0.040 | 100000 | 1 |
0.044 | 500000 | 1 |
0.060 | 17225 | 1 |
Last trade - 15.29pm 15/07/2024 (20 minute delay) ? |
Featured News
CF1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online